Cancer Molecular Pathology and Therapeutics ,MSc

    Cancer Molecular Pathology and Therapeutics ,MSc

    Duration1 year(s)
    Tuition Fee
    GBP 31,426 / Year
    Next IntakeSeptember 1, 2026

    Cancer Molecular Pathology and Therapeutics ,MSc

    About

    Join a world-leading cancer research centre by studying MSc Cancer Molecular Pathology and Therapeutics at one of the top research universities in the UK.

    The University of Leicester has a truly global reputation for its research into a range of clinical disciplines including molecular cancer therapeutics, heart disease, diabetes and genetics. The University is also home to the prestigious Leicester Cancer Research Centre, which conducts real-life trials and lifesaving research into this terrible disease.

    By studying Cancer Molecular Pathology and Therapeutics at postgraduate level, you will be taught by internationally-renowned researchers and clinicians at the forefront of cancer research and treatment, being equipped with the knowledge, expertise and experience to make a real positive contribution towards the future research and treatment of cancer.

    You will study the mechanistic nature of cancer biology and apply that knowledge to better understanding and developing the future diagnosis, prognosis therapy and prevention of cancer. Building on a solid foundation of learned basic cancer cell biology, you will consider and experience the design of treatment modalities and prevention strategies, including the mechanisms of action of anti-cancer drugs and radiation treatment, therapy resistance and biomarker discovery.

    This Cancer Therapeutics Masters degree course comprises three months of intensive lectures, tutorials and taught lab work, followed by a further month of advanced topic lectures delivered by scientists at the cutting-edge of translational research, focusing on therapeutics and prevention.

    A key component of the course is then the five to six month research project, which will give you the opportunity to study and research one of the department’s key research areas in much greater depth. As well as developing your understanding of the processes and techniques used in cancer research, you will learn how to critically analyse research data and research papers and how to communicate complex scientific concepts and processes, as well as contributing to the world-leading research that each laboratory undertakes.

    Requirements

    Entry Requirements

    2:2 degree (or equivalent) in a relevant bioscience subject such as biology, molecular biology, biochemistry, biotechnology, pharmacology etc.

    We also welcome applicants with significant relevant industrial or professional experience, and medically qualified applicants with a strong background in molecular biology and/or cell biology.

    English Language Requirements

    IELTS 6.5 or equivalent. If your first language is not English, you may need to provide evidence of your English language ability. If you do not yet meet our requirements, our English Language Teaching Unit (ELTU) offers a range of courses to help you to improve your English to the necessary standard.

    International Qualifications

    Find your country in this list to check equivalent qualifications, scholarships and additional requirements.

    Countries list

    English Program Requirements

    IELTS 6.5 or equivalent. If your first language is not English, you may need to provide evidence of your English language ability. If you do not yet meet our requirements, our English Language Teaching Unit (ELTU) offers a range of courses to help you to improve your English to the necessary standard.

    Career

    Careers and employability

    Your career development is a priority and by studying MSc Cancer Molecular Pathology and Therapeutics, you will be prepared for a dynamic career in medical research.

    Our graduates go on to a range of careers within the field including Molecular Diagnostics Consultant, Medical Researcher and roles at specialist institutes such as the Oxford Biomedical Research Centre.

    The MSc Cancer Molecular Pathology and Therapeutics can also prepare you for further academic study and research, as University of Leicester qualifications are welcomed by institutions across the globe. Many of our graduates become funded PhD, DTP and DPhil students and go on to become university Lecturers themselves.

    International students who study at the University of Leicester may be eligible for a Graduate Visa which grants permission to stay in the UK for at least 2 years after successful completion of their course.

    Our Career Development Service is here to support you, with advice on interviews, CVs, work experience, volunteering and more. From Freshers’ Week to Graduation and beyond, they are here to help you reach your professional goals.

    Fee Information

    Tuition Fee
    31,426 / year

    Cancer Molecular Pathology and Therapeutics ,MSc

    University of Leicester

    University of Leicester

    United Kingdom

    United Kingdom, Leicester